Cancerworld Magazine
  • About the Magazine
    • About us
    • Editorial Team
    • Events
    • Archive
    • Contacts
  • Articles
    • Policy
    • Practice Points
    • Delivery of Care
    • Biology basic
    • Medicine
    • Featured
  • Contents
    • News
    • Editorials
    • Interviews to the Expert
    • In the Hot Seat
    • Profiles
    • Obituaries
    • Voices
  • ESO College Corner
SUBSCRIBE FOR FREE
Facebook
Twitter
LinkedIn
Cancerworld Magazine
Cancerworld Magazine
  • About the Magazine
    • About us
    • Editorial Team
    • Events
    • Archive
    • Contacts
  • Articles
    • Policy
    • Practice Points
    • Delivery of Care
    • Biology basic
    • Medicine
    • Featured
  • Contents
    • News
    • Editorials
    • Interviews to the Expert
    • In the Hot Seat
    • Profiles
    • Obituaries
    • Voices
  • ESO College Corner
Cancerworld Magazine > 2020 > October

Posts by month

October 2020

10 posts
Dose dense chemotherapy in Luminal B breast cancers
View Post
  • Interviews to the Expert

Dose dense chemotherapy in Luminal B breast cancers

  • Alberto Costa
  • 26 October 2020

Interview with Lucia Del Mastro, MD, Department of Internal Medicine and Medical Specialties, School of Medicine, University of Genova, Italy. Q. Your recent paper in the European Journal of Cancer (EJC 136 (2020) 43-51) on the GIM2 trial is clearly…

View Post
A silver lining: Could changes forced by the pandemic point to better ways to conduct our clinical trials?
View Post
  • Articles
  • Policy

A silver lining: Could changes forced by the pandemic point to better ways to conduct our clinical trials?

  • Janet Fricker
  • 23 October 2020

Pragmatic adjustments to trial protocols were seen to be essential during the Covid-19 pandemic to avoid trials being abandoned or delayed. Most changes involved reducing the requirements for travelling to centralised trials centres and reducing the level of reporting requirements.…

View Post
Their fingers on the button: why neglecting radiation therapists is no longer an option
View Post
  • Articles
  • Delivery of Care

Their fingers on the button: why neglecting radiation therapists is no longer an option

  • Sophie Fessl
  • 21 October 2020

The job of a radiation therapist may sound straightforward: deliver the right dose of radiation to the right location. But it’s not. These are complex tasks that involve working with data, high-tech equipment and patients. Moreover, by doing each task…

View Post
Four steps to eliminating HPV-related cancers: a call for action
View Post
  • News

Four steps to eliminating HPV-related cancers: a call for action

  • Janet Fricker
  • 16 October 2020

A new report underlines that vaccination, screening, treatment and public awareness, provide the cornerstone for eliminating cancers linked to the human papillomavirus (HPV) in Europe. The report was published by The European Cancer Organisation, Brussels on 7th October. The report,…

View Post
These COVID days
View Post
  • Editorials

These COVID days

  • Adriana Albini
  • 15 October 2020

‘Tackling cancer in interesting times’ was the theme of my first Editorial for Cancer World. I wrote that at the start of February this year, at a time when Europe remained largely oblivious to the implications of a new virus…

View Post
Delivering cancer care during the pandemic: lessons from the ‘first wave’
View Post
  • Articles
  • Delivery of Care

Delivering cancer care during the pandemic: lessons from the ‘first wave’

  • Anna Wagstaff
  • 7 October 2020

“My partner had to be admitted to hospital with neutropenia earlier on in her treatment cycle, and she and I are constantly discussing what to do: whether we should ask about suspending treatment, how the risk/benefit equation adds up, whether…

View Post
Smoke without fire? Should cancer of unknown primary be treated as a separate disease?
View Post
  • Articles
  • Medicine

Smoke without fire? Should cancer of unknown primary be treated as a separate disease?

  • Sophie Fessl
  • 7 October 2020

Metastases, but no primary tumour – the diagnosis ‘cancer of unknown primary’ still presents great challenges, even in this age of precision oncology. Cancer of unknown primary (CUP) is an entity that encompasses a heterogenous group of metastatic cancers without…

View Post
Cancer deaths fall, health disparities persist, cancer research affected, reports AACR
View Post
  • News

Cancer deaths fall, health disparities persist, cancer research affected, reports AACR

  • Janet Fricker
  • 6 October 2020

The American Association for Cancer Research (AACR) annual Cancer Progress Report for 2020, published 23 September, portrays a mixed picture. On a positive note, the report features advances in cancer treatment and falls in cancer-related deaths; while on the negative…

View Post
Metastatic prostate cancer: cabazitaxel shows quality of life benefits over both abiraterone and enzalutamide
View Post
  • News

Metastatic prostate cancer: cabazitaxel shows quality of life benefits over both abiraterone and enzalutamide

  • Janet Fricker
  • 6 October 2020

In addition to previously reported survival benefits, the taxane cabazitaxel improved quality of life in patients with advanced metastatic prostate cancer compared to the androgen signalling targeted inhibitors abiraterone and enzalutamide, reports the latest analysis of the CARD trial (Fizazi…

View Post
Combined therapies offer the key to drug-resistant cancer
View Post
  • News

Combined therapies offer the key to drug-resistant cancer

  • Janet Fricker
  • 5 October 2020

For the first time, an investigator initiated phase 1b study tested the combination of the PARP inhibitor olaparib, and the AKT inhibitor capivasertib, and showed this combination was well tolerated and achieved durable responses in patients with treatment-refractory breast, ovarian…

View Post
search
CancerWorld #105 Download CancerWorld #104 Download CancerWorld #103 Download CancerWorld #102 Download CancerWorld #101 Download or search in Cancerworld archive
Newsletter

Subscribe free to
Cancerworld!

We'll keep you informed of the latest features and news with a fortnightly email

Subscribe now
Latest News
  • How a Brain-Destroying Protein Became Cancer’s Ally: Alpha-Synuclein Emerges as a New Target in Melanoma
    • 4 July 2025
  • CancerWorld #105 (July 2025)
    • 2 July 2025
  • How a Chicken Egg Model Could Transform Pediatric Cancer Treatment in Canada
    • 20 June 2025
  • Microbiota-Derived Bile Acids as Androgen Receptor Antagonists Enhance Anti-Tumour Immunity
    • 19 June 2025
  • Strategies Needed to Prioritise Screening in Survivors of Childhood Cancer
    • 4 June 2025
Article
  • Suheir Rasul: Protecting Human Dignity
    • 4 July 2025
  • Equity:The Word That Shaped Her Career From The Lab To The White House:The Story Of Catharine Young
    • 4 July 2025
  • Curious, Rejected,Accepted: An ESO Fellow’s Road to Becoming an Oncologist
    • 3 July 2025
Social

Would you follow us ?

Contents
  • Suheir Rasul: Protecting Human Dignity
    • 4 July 2025
  • Equity:The Word That Shaped Her Career From The Lab To The White House:The Story Of Catharine Young
    • 4 July 2025
  • Curious, Rejected,Accepted: An ESO Fellow’s Road to Becoming an Oncologist
    • 3 July 2025
MENU
  • About the Magazine
    • About us
    • Editorial Team
    • Events
    • Archive
    • Contacts
  • Articles
    • Policy
    • Practice Points
    • Delivery of Care
    • Biology basic
    • Medicine
    • Featured
  • Contents
    • News
    • Editorials
    • Interviews to the Expert
    • In the Hot Seat
    • Profiles
    • Obituaries
    • Voices
  • ESO College Corner
Cancerworld Magazine
  • About us
  • Articles
  • Media Corner
  • Privacy Policy
  • Cookie Policy

Cancerworld is published by OncoDaily (P53 Inc.) | Mailing Address: 867 Boylston st, 5th floor, Ste 1094 Boston, MA 02116, United States | [email protected]

Archivio Cancerworld

Input your search keywords and press Enter.